Amoxicillin + Clavulanic Acid

Formulations: - Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt) - Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 250 (as trihydrate) + 62.5 (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt) Indications: - Bacterial pneumonia (Community-acquired pneumonia - severe) [children] - Infectious cystitis - Neutropenia (low-risk) - Other specified pneumonia (Hospital-acquired pneumonia) - Bacterial cellulitis, erysipelas or lymphangitis - Peritonitis (mild-moderate) - Acute sinusitis - Peritoneal abscess (mild-moderate) - Chronic obstructive pulmonary disease with acute exacerbation - Bacterial pneumonia (Community-acquired pneumonia - mild to moderate) - Bacterial pneumonia (Community-acquired pneumonia - severe) - Bacterial infection of joint - Other specified prophylactic measures - Osteomyelitis or osteitis - Acute otitis media - Bacterial infection of unspecified site - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import